amobarbital has been researched along with Compensatory Hyperinsulinemia in 1 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic endogenous hyperinsulinemia produced by daily growth hormone treatment resulted in an insensitivity of the CNS glucoregulator center to exogenous insulin." | 1.25 | Studies on the nature and mode of action of the insulin-sensitive glucoregulator receptor in the central nervous system. ( Szabo, AJ; Szabo, O, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szabo, O | 1 |
| Szabo, AJ | 1 |
1 other study available for amobarbital and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Studies on the nature and mode of action of the insulin-sensitive glucoregulator receptor in the central nervous system.
Topics: Alloxan; Amobarbital; Animals; Blood Glucose; Cattle; Central Nervous System; Chemoreceptor Cells; D | 1975 |